Life-Saving Breakthroughs: A Spotlight on Reviva and Aridis Pharmaceuticals

11 months ago
40
Aridis Pharmaceuticals Monoclonal Antibodies (mAbs) Bacterial Infections Ventilator Associated Pneumonia (VAP) Hospital Acquired Pneumonia (HAP) Reviva biopharmaceutical central nervous system respiratory diseases metabolic diseases drug candidates

This week’s episode of the RedChip Money Report includes interviews with senior executives from Aridis Pharmaceuticals (OTC: ARDS) & Reviva Pharmaceuticals (NASDAQ: RVPH). Learn more at RedChip.com!

Loading comments...